Multicenter Registry Study to Identify the Frequency of Undetected Atrial Fibrillation in Actual Clinical Practice (REAL AF study)

Multicenter Registry Study to Identify the Frequency of Undetected Atrial Fibrillation in Actual Clinical Practice (REAL AF study) - Multicenter Registry Study to Identify the Frequency of Undetected Atrial Fibrillation in Actual Clinical Practice (REAL AF study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020096

Enrollment

1000

Registered

2015-12-08

Start date

2016-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1.Heart failure/left ventricular dysfunction* 2.Hypertension 3.Diabetes mellitus 4.Vascular disease (myocardial infarction, past history of angina pectoris, peripheral artery disease, and aortic plaque) 5.Past history of cerebral infarction/transient ischemic attack (TIA) 6.Cardiomyopathy (hypertrophic, dilated, restrictive, arrhythmogenic right ventricular cardiomyopathy, and unclassifiable) * Refers to the case where the left ventricular ejection fraction is less than 40%.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients aged 65 years or older without a past history of atrial fibrillation who have at least 1 of the following factors: 1.Heart failure/left ventricular dysfunction* 2.Hypertension 3.Diabetes mellitus 4.Vascular disease (myocardial infarction, past history of angina pectoris, peripheral artery disease, and aortic plaque) 5.Past history of cerebral infarction/transient ischemic attack (TIA) 6.Cardiomyopathy (hypertrophic, dilated, restrictive, arrhythmogenic right ventricular cardiomyopathy, and unclassifiable) * Refers to the case where the left ventricular ejection fraction is less than 40%.

Exclusion criteria

Exclusion criteria: 1.History of atrial fibrillation 2.Patients in whom thromboembolism or myocardial infarction has developed within 2 months before registration 3.Patients who have undergone implantation of pacemakers, implantable defibrillators, biventricular pacemakers, implantable defibrillators with biventricular pacing function, and loop recorders 4.Patients who have undergone prosthetic valve replacement 5.Pregnant women, lactating women, and women who may possibly be pregnant 6.Other patients judged inappropriate by the principal investigator or subinvestigator

Design outcomes

Primary

Measure	Time frame
To reveal the actual frequency of outpatients with atrial fibrillation, including asymptomatic atrial fibrillation, in Japan.	—

Secondary

Measure	Time frame
To reveal the presence or absence of anticoagulation therapy when detecting one atrial fibrillation.	—

Countries

Japan

Contacts

Public ContactYukimi Kokubun

RPM Co.,Ltd Clinical Development Div

realaf-office@umin.org03-5325-5821

Outcome results